OARSI, ISIAT, SFR: Our poster presentations and oral communications

Before publication in a peer-reviewed journal, we communicate and present our work and research findings at important scientific meetings and medical conferences. Several research abstracts have already been displayed and presented on oversized posters at different meetings. Please find them below: CUIVRAMINE DIFFERENTIAL IMPACT OF GLUCOSAMINE SULFATE AND CUIVRAMINE® ON Read more…

INNOVATION: HAPPYCROSS®, 1.6% Cross-linked Hyaluronic Acid + Mannitol for ankle, hip and shoulder osteoarthritis (1 x 2.2ml syringe)

SECOND GENERATION VISCOSUPPLEMENT  INDICATED IN THE TREATMENT OF ANKLE, HIP & SHOULDER OSTEOARTHRITIS UNIQUE COMBINATION OF CROSS-LINKED HYALURONIC ACID + MANNITOL MEDICAL DEVICE – 1 x 2.2 ml pre-filled syringe (SINGLE INTRA-ARTICULAR INJECTION)   High concentration for prolonged activity HAppyCross™ contains high concentration of hyaluronic acid (1.6%) i.e. 35.2 mg/syringe. Read more…

NEW: HAPPYVISC®, 1.55% Hyaluronic Acid + Mannitol to treat knee osteoarthritis (3 x 2ml syringes)

SECOND GENERATION VISCOSUPPLEMENT INDICATED IN THE TREATMENT OF KNEE OSTEOARTHRITIS HYALURONIC ACID + MANNITOL MEDICAL DEVICE – 3 x 2 ml pre-filled syringes   High Molecular Weight HAppyVisc™ is a visco-elastic gel which combines high molecular weight hyaluronic acid of 1.5 million Daltons and mannitol. High concentration for prolonged activity Read more…

About LABRHA

Founded by Patrick Sac-Epée in 2005 in the city of Lyon in France, LABRHA is dedicated to the conception and development of natural products in rheumatology. OUR MISSION LABRHA’s mission is to meet patients’ and practitioners’ needs helping them to find, in the management of rheumatic diseases and musculoskeletal pains, Read more…